KLK3 and posterior cortical atrophy: In our experience, the prevalence of PCa was significantly lower in patients with BOO than in patients without BOO (33.1% vs 66.9%; P < 0.0001); such difference was even greater (30% vs 70%; P < 0.0001) in the subset of patients with PSA ≤10 ng/mL.